Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke
L Nie, D Yao, S Chen, J Wang, C Pan, D Wu… - Cell Death …, 2023 - nature.com
Due to the limited capacity of the adult mammalian brain to self-repair and regenerate,
neurological diseases, especially neurodegenerative disorders and stroke, characterized by …
neurological diseases, especially neurodegenerative disorders and stroke, characterized by …
Drug screening for human genetic diseases using iPSC models
Induced pluripotent stem cells (iPSCs) enable the generation of previously unattainable,
scalable quantities of disease-relevant tissues from patients suffering from essentially any …
scalable quantities of disease-relevant tissues from patients suffering from essentially any …
Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease
Z Wu, M Parry, XY Hou, MH Liu, H Wang, R Cain… - Nature …, 2020 - nature.com
Huntington's disease (HD) is caused by Huntingtin (Htt) gene mutation resulting in the loss
of striatal GABAergic neurons and motor functional deficits. We report here an in vivo cell …
of striatal GABAergic neurons and motor functional deficits. We report here an in vivo cell …
CRISPR-Cas9-mediated genome editing increases lifespan and improves motor deficits in a Huntington's disease mouse model
FK Ekman, DS Ojala, MM Adil, PA Lopez… - … Therapy-Nucleic Acids, 2019 - cell.com
Huntington's disease (HD) is a currently incurable and, ultimately, fatal neurodegenerative
disorder caused by a CAG trinucleotide repeat expansion within exon 1 of the huntingtin …
disorder caused by a CAG trinucleotide repeat expansion within exon 1 of the huntingtin …
Electrophysiology, unplugged: imaging membrane potential with fluorescent indicators
P Liu, EW Miller - Accounts of chemical research, 2019 - ACS Publications
Conspectus Membrane potential is a fundamental biophysical property maintained by every
cell on earth. In specialized cells like neurons, rapid changes in membrane potential drive …
cell on earth. In specialized cells like neurons, rapid changes in membrane potential drive …
Cell encapsulation and 3D bioprinting for therapeutic cell transplantation
The promise of cell therapy has been augmented by introducing biomaterials, where
intricate scaffold shapes are fabricated to accommodate the cells within. In this review, we …
intricate scaffold shapes are fabricated to accommodate the cells within. In this review, we …
Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease
YY Wu, FL Chiu, CS Yeh… - Royal Society Open …, 2019 - royalsocietypublishing.org
Adult-onset neurodegenerative diseases are among the most difficult human health
conditions to model for drug development. Most genetic or toxin-induced cell and animal …
conditions to model for drug development. Most genetic or toxin-induced cell and animal …
Cell therapy in Huntington's disease: Taking stock of past studies to move the field forward
AC Bachoud-Lévi, R Massart, A Rosser - Stem Cells, 2021 - academic.oup.com
Huntington's disease (HD) is a rare inherited neurodegenerative disease that manifests
mostly in adulthood with progressive cognitive, behavioral, and motor dysfunction. Neuronal …
mostly in adulthood with progressive cognitive, behavioral, and motor dysfunction. Neuronal …
Huntington's disease: complex pathogenesis and therapeutic strategies
H Tong, T Yang, S Xu, X Li, L Liu, G Zhou… - International Journal of …, 2024 - mdpi.com
Huntington's disease (HD) arises from the abnormal expansion of CAG repeats in the
huntingtin gene (HTT), resulting in the production of the mutant huntingtin protein (mHTT) …
huntingtin gene (HTT), resulting in the production of the mutant huntingtin protein (mHTT) …
On the right track to treat movement disorders: promising therapeutic approaches for Parkinson's and Huntington's disease
P Troncoso-Escudero, D Sepulveda… - Frontiers in aging …, 2020 - frontiersin.org
Movement disorders are neurological conditions in which patients manifest a diverse range
of movement impairments. Distinct structures within the basal ganglia of the brain, an area …
of movement impairments. Distinct structures within the basal ganglia of the brain, an area …